about
Emergent properties of neural repair: elemental biology to therapeutic conceptsAkt-dependent metabolic reprogramming regulates tumor cell histone acetylationMolecular Targets and Treatment of Meningioma.Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma.Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomasOxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression dataEmerging insights into the molecular and cellular basis of glioblastoma.Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells.MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastomaPharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways.PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.Progress on molecular biomarkers and classification of malignant gliomas.The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system diseasePI3K/AKT signaling pathway and cancer: an updated review.Molecular prognostic factors in glioblastoma: state of the art and future challenges.Chromosomal Instability and Phosphoinositide Pathway Gene Signatures in Glioblastoma MultiformeManaging teenage/young adult (TYA) brain tumors: a UK perspective.Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis.Fangchinoline suppresses the growth and invasion of human glioblastoma cells by inhibiting the kinase activity of Akt and Akt-mediated signaling cascades.Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas.Silencing of the hTERT gene through RNA interference induces apoptosis via bax/bcl-2 in human glioma cellsNeoalbaconol inhibits cell growth of human cholangiocarcinoma cells by up-regulating PTEN.Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment.Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis.DNA methylation, histone modifications, and signal transduction pathways: a close relationship in malignant gliomas pathophysiology.ENTPD5-mediated modulation of ATP results in altered metabolism and decreased survival in gliomablastoma multiforme.The role and mechanism of β‑arrestins in cancer invasion and metastasis (Review).The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.
P2860
Q28067303-AA1149A4-5353-4DE6-8EEE-E589B154077BQ34117812-08EC17CA-5294-4E80-9C86-B056AE624FB5Q34631513-487C4AAE-6DB9-431C-A77C-02662AA8DC19Q35143738-F24C940B-28E0-4992-B618-7B69766867C4Q35171890-23C389CD-F3D3-4F1B-A0B7-2D6F010E7933Q35234429-8ED26AD8-D8EB-4917-870D-AADC7E051114Q35624037-A7CFB283-6A43-44AD-886B-834A2AB62CB1Q35914897-B60E95D1-46DD-4509-B2A5-96D64107C6E7Q35973580-E95C4C8D-AF5D-4314-970C-ADCC868520DBQ36580732-C2DA3097-36CE-4C14-8884-932CE175E207Q36630698-BBE4C296-3188-4AB9-8174-251D54D1D87FQ36916729-B9F30160-C3C3-4047-900A-74B59E3562C1Q37426405-8A912968-5A6E-4513-A3F2-51484C7F7D68Q38107462-F29E5255-1160-4917-8DDA-0887F2E575B2Q38124430-1F285A0E-6E28-49B6-9414-74AAB93B9D30Q38217651-75719B9B-B364-4261-981E-B2AEF60C6965Q38233134-3EA62509-9B7E-4C14-9917-4EF59D25DF5BQ38388784-56158BC5-791F-4752-813E-BD1A3AE47C14Q38539466-E15CFE46-3EFF-422D-A532-F9CFF6F07CC4Q38770981-42ABFF8B-A66A-4ED4-9495-6DDA18CBA75CQ38832384-D8E130D8-1513-4D8D-9242-D1135D0E1871Q38958545-4723574C-6A93-4500-A743-65ABEF74D1A1Q39296941-08212574-0EDA-4FFA-9922-EB1D37E4A6A2Q40682768-B50C6858-D709-49C1-A7B9-B66494FFAEA7Q41459815-6DA00912-1255-492D-9234-666C45FAB981Q41541275-70CA8B7A-0D25-4BC2-AF16-21A0D72EE7B4Q42090451-F82E29A3-FDC0-46CB-B0BE-994A31E0F182Q46063316-14B3D234-E2AA-45CC-8083-8FAF03546E35Q47328865-541991FB-070A-4DED-AB1E-899BEB293C5AQ47868509-1D8A5CB5-4974-4A79-83DF-322ED860E783
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
PI3Kinase signaling in glioblastoma.
@en
PI3Kinase signaling in glioblastoma.
@nl
type
label
PI3Kinase signaling in glioblastoma.
@en
PI3Kinase signaling in glioblastoma.
@nl
prefLabel
PI3Kinase signaling in glioblastoma.
@en
PI3Kinase signaling in glioblastoma.
@nl
P2860
P921
P1476
PI3Kinase signaling in glioblastoma.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11060-010-0442-Z
P577
2010-11-10T00:00:00Z
2011-07-01T00:00:00Z